Invitation for Abstract Submissions: ALFC 2025
The
Advanced Lateral Flow Conference (ALFC) is excited to announce that it is now accepting applications for poster presentations for its upcoming event scheduled for
October 14-15, 2025, at the Hilton La Jolla Torrey Pines in
La Jolla, California. This annual conference serves as a crucial gathering place for professionals immersed in the rapid diagnostics sector, including scientists, engineers, founders, and regulatory experts, all eager to share valuable insights and catalyze advancements in lateral flow technology.
Conference Theme and Topics
This year’s theme,
"Catalyzing Growth: Tech Advancements, Funding, and Regulatory Roadmaps in LFA", addresses the complex real-world issues faced by diagnostics developers. This theme aims to bring to light critical topics including:
- - Funding and Investment Strategies: Delving into early-stage capital, milestone deals, and non-dilutive funding options.
- - Commercial Strategy & Market Access: Examining pricing, reimbursement strategies, and go-to-market approaches.
- - Product Development: Focused on technology transfer, cost modeling, and considerations for manufacturability.
- - Regulatory Challenges: Discussing FDA compliance, global regulatory structures, and planning based on risk management.
- - Emerging Use Cases: Covering applications across antimicrobial resistance (AMR), veterinary diagnostics, environmental testing, and pharmaceutical sectors.
The Poster Session: A Platform for Innovation
Presenting a poster at ALFC provides a unique opportunity for researchers and developers to showcase their findings, whether they are highlighting scientific validations, innovative technical applications, or practical lessons from the field. This year’s poster submissions are designed to ignite discussions and foster partnerships among attendees, creating a vibrant atmosphere for innovative exchange.
Submission Guidelines
Submissions can range from research outcomes to insights into product development, case studies, or implementation outcomes. When preparing your abstract, it should comprehensively detail:
- - What you are presenting and the significance of your work.
- - Supporting data or experiences that back your conclusions.
- - Key takeaways that your peers can benefit from.
All submissions must be original, not previously published, and must refrain from promotional content. Submissions are welcome until
June 30, 2025.
Why Attend ALFC 2025?
ALFC142 025 is more than just a conference; it’s a melting pot of expertise, innovation, and networking for the lateral flow diagnostic community. By participating, attendees will gain substantial insights into advancements in rapid diagnostics, while also having the opportunity to connect with leaders in the field and collaborate on forward-thinking projects.
To apply to submit a poster abstract, please visit
alfc2025.com for more information.
About DCN Dx
DCN Dx, based in
Carlsbad, California, is a leader in lateral flow diagnostic development and manufacturing, along with IVD regulatory consulting and clinical research. The organization excels in offering tailored assay systems and clinical operations, supporting clients through every phase of product development. DCN Dx continues to set new benchmarks in quality and innovation, ensuring that diagnostics meet the highest standards.
Visit
dcndx.com for further details on their services and how they can aid your diagnostic projects.
For inquiries, contact:
Mitzi Rettinger
Chief Revenue Officer, DCN Dx
Phone: (760) 804-3886
Mobile: (512) 431-5836
Email: [email protected]